Revilliza, Kevin Patrick F.
HRN: 22-17-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2022
CEFUROXIME 1.5GM (VIAL)
11/07/2022
11/14/2022
IV
1.5
Q8h
For Inguinal Repair
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes